Keyphrases
Tyrosine Hydroxylase
74%
Substantia Nigra
48%
Parkinson's Disease
47%
Aging
44%
Dopamine
43%
Striatum
41%
Tyrosine Hydroxylase Phosphorylation
34%
Striatal Dopamine
28%
Nigrostriatal System
28%
Parkinson's Disease Model
26%
Glial Cell Line-derived Neurotrophic Factor
24%
Striatal
21%
Phosphorylation
21%
Tyrosine Hydroxylase Expression
20%
Dopaminergic Regulation
19%
Aged Rats
18%
6-hydroxydopamine (6-OHDA)
17%
Knockout Rat
17%
Dopamine Transporter
16%
Locomotor Activity
15%
Dopaminergic Pathway
15%
Motor Decline
13%
Mesoaccumbens
11%
Motor Impairment
11%
Parkinsonian Signs
10%
Methamphetamine
10%
Dyskinesia
10%
Caloric Restriction
10%
Aerobic Exercise
10%
Cognitive Decline
9%
Glutamate Transporter 1 (GLT-1)
9%
Ventral Tegmental Area
9%
L-DOPA
9%
Rodents
9%
Nigrostriatal Neurons
9%
Striatal Lesion
9%
Premotor
8%
Locomotor
8%
Dopamine Level
8%
Locomotor Decline
8%
Moderate Exercise
7%
Tissue Content
7%
Early Parkinson's Disease
7%
EAAC1
7%
Dopamine Uptake
7%
6-Hydroxydopamine-lesioned Rats
7%
Mouse Model
7%
Cognitive Deficits
7%
Bradykinesia
7%
Neuron Loss
7%
Neuroscience
Tyrosine Hydroxylase
100%
Parkinson's Disease
68%
Substantia nigra
49%
Striatum
45%
Glial Cell Line-Derived Neurotrophic Factor
30%
Dopamine Transporter
19%
Stereotypic Movement Disorder
19%
Dopamine Beta Hydroxylase
18%
Locomotor Activity
18%
Glutamic Acid
13%
In Vivo
12%
Behavior (Neuroscience)
11%
Ventral Tegmental Area
10%
Oxidopamine
10%
Cognitive Disorders
9%
L-DOPA
9%
Anabolism
7%
Parkinsonism
7%
Receptor
7%
Dopamine Uptake
7%
Bradykinesia
7%
Nucleus Accumbens
7%
Ceftriaxone
6%
Dyskinesia
6%
Cell Membrane
6%
Catecholamine
6%
Dopamine Release
5%
Nigrostriatal Pathway
5%
Serine
5%
Neurodegenerative Disorder
5%
Reuptake
5%